Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 9
1987 2
1988 1
1989 4
1990 1
1992 1
1993 1
1994 2
1995 3
1996 2
1997 6
1998 4
1999 3
2000 3
2001 5
2002 3
2003 6
2004 17
2005 16
2006 5
2007 12
2008 17
2009 9
2010 10
2011 10
2012 5
2013 3
2014 3
2015 4
2016 6
2017 8
2018 9
2019 10
2020 8
2021 7
2022 7
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Results by year

Filters applied: . Clear all
Page 1
Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study.
Swain SM, Ewer MS, Viale G, Delaloge S, Ferrero JM, Verrill M, Colomer R, Vieira C, Werner TL, Douthwaite H, Bradley D, Waldron-Lynch M, Kiermaier A, Eng-Wong J, Dang C; BERENICE Study Group. Swain SM, et al. Among authors: colomer r. Ann Oncol. 2018 Mar 1;29(3):646-653. doi: 10.1093/annonc/mdx773. Ann Oncol. 2018. PMID: 29253081 Free PMC article. Clinical Trial.
Advanced breast cancer clinical nursing curriculum: review and recommendations.
Vila C, Reñones C, Ferro T, Peñuelas MÁ, Del Mar Jiménez M, Rodríguez-Lescure Á, Muñoz M, Colomer R. Vila C, et al. Among authors: colomer r. Clin Transl Oncol. 2017 Feb;19(2):251-260. doi: 10.1007/s12094-016-1530-0. Epub 2016 Aug 3. Clin Transl Oncol. 2017. PMID: 27488905 Free PMC article. Review.
Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study.
Tan AR, Im SA, Mattar A, Colomer R, Stroyakovskii D, Nowecki Z, De Laurentiis M, Pierga JY, Jung KH, Schem C, Hogea A, Badovinac Crnjevic T, Heeson S, Shivhare M, Kirschbrown WP, Restuccia E, Jackisch C; FeDeriCa study group. Tan AR, et al. Among authors: colomer r. Lancet Oncol. 2021 Jan;22(1):85-97. doi: 10.1016/S1470-2045(20)30536-2. Epub 2020 Dec 21. Lancet Oncol. 2021. PMID: 33357420 Clinical Trial.
[Vaccines and breast cancer].
Colomer R. Colomer R. Med Clin (Barc). 2008 Nov 22;131(18):692-3. doi: 10.1157/13129119. Med Clin (Barc). 2008. PMID: 19087827 Spanish. No abstract available.
[Treatment of lymphoma in the aged].
Gómez H, Colomer R. Gómez H, et al. Among authors: colomer r. Med Clin (Barc). 1998 May 2;110(15):574-5. Med Clin (Barc). 1998. PMID: 9650201 Review. Spanish. No abstract available.
Current controversies in the management of breast cancer.
Tusquets I, García-Estévez L, Adrover E, Calvo L, Alvarez I, García Mata J, Fernández Y, Margueli M, Seguí MA, Muñoz M, Rodríguez C, Rodríguez Lescure A, Colomer R, Gascón P, Martín M, Alba E, Barnadas A, Llombart A, Albanell J, Lluch A. Tusquets I, et al. Among authors: colomer r. Clin Transl Oncol. 2010 Apr;12(4):278-86. doi: 10.1007/s12094-010-0504-x. Clin Transl Oncol. 2010. PMID: 20462837 Review.
199 results